ibl.ai Agentic AI Blog

Insights on building and deploying agentic AI systems. Our blog covers AI agent architectures, LLM infrastructure, MCP servers, enterprise deployment strategies, and real-world implementation guides. Whether you are a developer building AI agents, a CTO evaluating agentic platforms, or a technical leader driving AI adoption, you will find practical guidance here.

Topics We Cover

Featured Research and Reports

We analyze key research from leading institutions and labs including Google DeepMind, Anthropic, OpenAI, Meta AI, McKinsey, and the World Economic Forum. Our content includes detailed analysis of reports on AI agents, foundation models, and enterprise AI strategy.

For Technical Leaders

CTOs, engineering leads, and AI architects turn to our blog for guidance on agent orchestration, model evaluation, infrastructure planning, and building production-ready AI systems. We provide frameworks for responsible AI deployment that balance capability with safety and reliability.

Back to Blog

Can AI Agents Cut Platelet Waste? Hospital Logistics Evidence

ibl.ai EngineeringNovember 2, 2026
Premium

Platelets last days, and a 2020 paper put US outdating near 16%. Sharing policy cut outdates about 20% at Emory, and simulation points to more. The evidence favours hospital logistics as an agent job, and the hard part is shared data.

The Short Answer

AI agents could plausibly cut platelet waste by coordinating transfers, but the proven gain so far comes from a sharing policy, and AI results are mostly simulated. A 2020 paper put US outdating near 16%. The hard part is shared inventory data and permissions. With ibl.ai you own all the code and the data, behind your firewall.

A recent social post described a hospital developer building an agent for platelet sharing. We could not find a named system, so nothing here rests on it. The idea can be tested against published evidence, and that evidence is useful.

Why do hospitals waste platelets?

Hospitals waste platelets because the product expires in days and demand is hard to predict.

Storage in the US was limited to five days for many years because of bacterial risk, and a 2020 paper put the national outdate rate at about 16%. Seven-day storage is now possible with cleared safety measures.

That 16% is the only national figure we found, and it is six years old. Treat it as a rough size, not a current rate. A UK study describes a shelf life of 3 to 5 days, and reports that 8 to 10% of issued platelets came back unused from wards, many too near expiry to reuse.

Does sharing platelets between hospitals reduce waste?

Yes, and the strongest evidence involves no AI at all.

A study in Operations Research developed a transshipment policy for moving platelets between two hospitals. Implemented in the Emory University Hospital System, it reduced outdates by about 20%, and summaries of the paper report no increase in shortages.

That result sets the bar. A written rule, followed reliably, moved the number. Before a hospital buys an agent, it should ask whether it has already tried the rule.

What has AI added to platelet inventory management?

AI has added forecasting and smarter decisions, mostly in research settings. A 2025 review in Acta Haematologica calls these advances "largely exploratory" and says models need rigorous validation.

ApproachResultEvidence type
Sharing policy between two hospitals (Emory)About 20% fewer outdatesImplemented
Issuing the youngest unit when a return is predicted (UK)About 14% less wastageSimulation at one hospital
Reinforcement learning across a hospital networkLower wastage and cost than base-stock orderingModelled study
Facility-level optimization, across reviewed studiesOutdating roughly halved, for forecasting at facility levelSystematic review, mostly retrospective simulation

The network study is closest to the sharing idea. It models near-expiry units moving from smaller local hospitals to larger ones. It is still a model, and the review's figures come from varied settings, so don't add these gains together.

What would an AI agent do in hospital blood logistics?

An agent would handle the coordination around a decision that a person still makes. That work already exists.

Through Versiti's Platelet Partners in Michigan, hospitals post same-day-expiring units for hospitals in other systems to claim. Shipping is arranged between the two hospitals, because Versiti does not provide transportation.

A sensible first agent would do four things, none of them clinical:

  • Watch expiry dates against a forecast and flag units at risk.
  • Find nearby partners with a likely need, and draft the offer.
  • Chase the reply, and draft the transport request.
  • Log every step for the blood bank's records.

The blood bank's staff approve each transfer. Keep the agent out of transfusion decisions. As our look at hospital agent testing found, tasks that change a record are where agents do worse, so a person stays on every write.

Why is hospital logistics a better first AI project than diagnosis?

Hospital logistics is a good first project because the result is countable and a mistake is easier to catch. Units expired is a number a hospital already tracks. A diagnosis agent needs clinical validation, and its errors can reach a patient.

This isn't a claim that clinical AI is wasted. It is a question of order. Logistics also teaches an organization what it needs next: clean data, permissions, audit and a human in the loop.

What stops hospitals from sharing platelet inventory with AI?

Data access and agreements stop them, more than models do. Inventory lives in separate systems, and hospitals in different groups have little reason to expose it. As we have argued, healthcare AI tends to fail at the information layer.

The technical need is an ontology: a shared map that says a unit at one hospital is the same kind of thing as a unit at another, with an expiry, a type and an owner. Connectors then read each system in place, scoped by role, so nobody hands over a full copy of their data.

How does ibl.ai support hospital operations agents?

On ibl.ai, agents reach hospital systems through connectors, with Roles limiting access and Transcripts keeping the record of each conversation. Skills are plain Markdown, so a blood bank lead can write the procedure.

With ibl.ai you own all the code and the data, behind your own firewall. The platform is model-agnostic across any LLM, has no per-seat pricing, and you can deploy anywhere. See our guide to self-hosted AI for hospitals.

ibl.ai is family-owned and operated from New York, NY.

Sources: the Emory 20% figure is from the journal's abstract. Other figures are from the linked papers and reporting. None measures an AI agent in live blood logistics.

Why does owning the AI stack matter?

ibl.ai is the agentic AI platform where you own all the code and the data. You self-host the entire stack inside your own perimeter, run it model-agnostic across any LLM and switch anytime, and pay by usage with no per-seat pricing β€” so you can deploy anywhere: your cloud, on-premise, GovCloud, or fully air-gapped.

  • You own all the code and the data

    Full source code under a perpetual license, running on your infrastructure. Not API access to someone else's platform β€” the stack itself is yours.

  • Model-agnostic

    Run any LLM β€” Claude, GPT, Gemini, Llama, Command, or your own fine-tune β€” and switch providers without rewriting the platform.

  • No per-seat pricing

    Usage-based billing against a budget cap you set. Cost tracks what your organization actually uses, not how many people you employ.

  • Deploy anywhere

    Your cloud, your VPC, on-premise, GovCloud, or a fully air-gapped network with no outbound connectivity.

1.6M+ users across 400+ organizations run the platform this way, including NVIDIA, MIT, and Syracuse University.

ibl.ai is family-owned and operated from New York, NY β€” a U.S.-headquartered, domestically-owned long-term partner, not a vendor that sells licenses and moves on.

Related Articles

Healthcare AI Agents Need a Unified Patient Ontology

Self-hosted AI agents for healthcare break when patient data is scattered across EHR, scheduling, claims, and lab systems. The prerequisite is an ontology β€” a governed patient data layer the health system owns and runs itself β€” that unifies those silos before any agent is deployed.

Miguel AmigotJune 23, 2026

Self-Hosted AI Agents for Healthcare: PHI Never Leaves

Self-hosted AI agents for healthcare are autonomous clinical and administrative agents that run entirely inside your HIPAA-covered environment β€” reading from and writing to your EHR through connectors, with PHI never leaving the boundary. The agents, the architecture, the cost math, and why owning the stack is the defensible posture.

Mikel AmigotJune 8, 2026

Agent Skill Catalogs Are a Supply Chain. Who Signs Yours?

Enterprise teams have stopped asking how to deploy an agent and started asking who is allowed to publish a skill. NVIDIA's verified skill pipeline treats agent capabilities as signed software artifacts β€” which makes the catalog a supply chain, and raises the question of who holds the signing key.

Mikel AmigotAugust 24, 2026

Duplex Voice Agents Reach the Payer Phone Call. The $31 Billion Figure Is From 2009.

Decagon launched Voice 3 and its Chord speech model on 1 October 2026, bringing duplex voice agents that talk while they work. AI voice agents have called payers since 2019, so the news is the removal of hold time, not the arrival of the capability. Meanwhile the $31 billion prior authorization figure everyone quotes is a 2009 estimate covering every physician-plan interaction. The deployment question is control and evidence, not feasibility.

ibl.ai EngineeringOctober 3, 2026

See the ibl.ai AI Operating System in Action

Discover how leading universities and organizations are transforming education with the ibl.ai AI Operating System. Explore real-world implementations from Harvard, MIT, Stanford, and users from 400+ institutions worldwide.

View Case Studies
Work with our team

Pilots, deployment, and full ownership

Most enterprise engagements are one-time, not subscriptions. You integrate ibl.ai with your own data, deploy it on your own infrastructure, and the engineering hours scale with the work β€” so the price tracks the scope, not your headcount.

Start here

Pilot

from $15K

fixed scope Β· fixed timeline

A time-boxed proof of value on your real data β€” not a slide deck.

Best for: Teams that want to see ibl.ai working before committing.

  • Deployed on your infrastructure or our cloud
  • 1–2 production agents wired to a slice of your data
  • One integration (LMS / SIS / SSO / data source)
  • Weekly working sessions with our engineers
  • Pilot fee credits toward a full engagement
Scope a pilot
Most common

Integration & Deployment

$25K – $80K

one-time Β· not a subscription

Full deployment integrated with your data and systems. Engineering hours scale with scope.

Best for: Organizations rolling ibl.ai out across a department, campus, or business unit.

  • Platform deployed in your VPC, on-prem, or air-gapped
  • Integrated with your data + identity (SSO / SAML)
  • Multiple custom agents built to your workflows
  • Engineering hours proportional to scope
  • You own the data Β· run any LLM you choose
Plan a deployment
Full ownership

Codebase Transfer + Custom AI Engineering

Custom quote

perpetual license Β· you own the stack

We transfer the full source code. You own and self-host the entire platform β€” outright.

Best for: Organizations and enterprises that benefit from perpetual ownership and sovereignty.

  • Complete source-code transfer + perpetual license
  • Dedicated AI engineering team on your roadmap
  • Custom agents, models, and integrations to spec
  • Air-gapped capable Β· zero vendor lock-in
  • Family-owned, New York–based long-term partner
Talk about ownership
You own the code and data Run any LLM β€” Claude, GPT, Gemini, Llama Family-owned & operated from New York, NY